Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data.

MLA

Argyri, Katerina D., et al. “Numerical Simulation of Vascular Tumour Growth under Antiangiogenic Treatment: Addressing the Paradigm of Single-Agent Bevacizumab Therapy with the Use of Experimental Data.” Biology Direct, vol. 11, Mar. 2016, pp. 1–31. EBSCOhost, https://doi.org/10.1186/s13062-016-0114-9.

APA

Argyri, K. D., Dionysiou, D. D., Misichroni, F. D., Stamatakos, G. S., Hanin, L., Radivoyevitch, T., & Edler, L. (2016). Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data. Biology Direct, 11, 1–31. https://doi.org/10.1186/s13062-016-0114-9

Chicago

Argyri, Katerina D., Dimitra D. Dionysiou, Fay D. Misichroni, Georgios S. Stamatakos, L. Hanin, T. Radivoyevitch, and L. Edler. 2016. “Numerical Simulation of Vascular Tumour Growth under Antiangiogenic Treatment: Addressing the Paradigm of Single-Agent Bevacizumab Therapy with the Use of Experimental Data.” Biology Direct 11 (March): 1–31. doi:10.1186/s13062-016-0114-9.